Wed, February 19, 2025
[ Wed, Feb 19th 2025 ]: WOPRAI
As of Feb 19th, 2025, there has been substantial .. of United Health Products, Inc. in recent trading
[ Wed, Feb 19th 2025 ]: WOPRAI
As of Feb 19th, 2025, there has been substantial selling of G6 Materials Corp. in recent trading
[ Wed, Feb 19th 2025 ]: WOPRAI
As of Feb 19th, 2025, there has been substantial .. lling of Avance Gas Holding Ltd in recent trading
[ Wed, Feb 19th 2025 ]: WOPRAI
As of Feb 19th, 2025, there has been substantial selling of Mitesco, Inc. in recent trading
[ Wed, Feb 19th 2025 ]: WOPRAI
As of Feb 19th, 2025, there has been substantial .. ling of Bio-Path Holdings, Inc. in recent trading
[ Wed, Feb 19th 2025 ]: WOPRAI
As of Feb 19th, 2025, there has been substantial .. riguard Security Services, Inc. in recent trading
[ Wed, Feb 19th 2025 ]: WOPRAI
As of Feb 19th, 2025, there has been substantial .. ribal Rides International Corp. in recent trading
[ Wed, Feb 19th 2025 ]: WOPRAI
As of Feb 19th, 2025, there has been substantial selling of in recent trading
[ Wed, Feb 19th 2025 ]: Kiplinger
Can a Gold IRA Counter Sticky Inflation for Retirement?
[ Wed, Feb 19th 2025 ]: MSN
Muddy Waters CEO Carson Block on China, Elon Musk, Trump Tariffs and ESG Investing
Tue, February 18, 2025
[ Tue, Feb 18th 2025 ]: Mint
Stocks to buy on 19 February: Ankush Bajaj recommends three stocks for today
[ Tue, Feb 18th 2025 ]: Forbes
The Surprising History Of Tariffs And Their Role In U.S. Economic Policy
[ Tue, Feb 18th 2025 ]: MSN
It's time to buy memory stocks, Mizuho's TMT specialist tells clients
[ Tue, Feb 18th 2025 ]: MSN
Bancolombia S.A. (CIB): Among the Best Performing Bank Stocks So Far In 2025
[ Tue, Feb 18th 2025 ]: MSN
Complete guide to start investing without prior experience
[ Tue, Feb 18th 2025 ]: Forbes
Wall Street Has Lowest Exposure To Cash Since 2010 As U.S. Stock Exceptionalism Peaks, Survey Says
[ Tue, Feb 18th 2025 ]: MarketWatch
20 stocks of companies expected to put up numbers to back investors' new 'growth mindset'
[ Tue, Feb 18th 2025 ]: bnnbloomberg
YouTuber Is Closing His ETF After Performance Woes, Soaring Costs
[ Tue, Feb 18th 2025 ]: AOL
I made a small fortune on Bitcoin. What should I do to diversify my portfolio?
[ Tue, Feb 18th 2025 ]: MSN
I'm 65 and set to retire with $500,000 in the bank. How long will that last?
[ Tue, Feb 18th 2025 ]: MoneyWeek
Defence stocks rise as UK faces "generational challenge" on national security
[ Tue, Feb 18th 2025 ]: MSN
An Investing Riddle: Stocks Are in Turmoil but Stock Markets Aren't
[ Tue, Feb 18th 2025 ]: Invezz
Retire rich with these blue-chip dividend ETFs (excluding SCHD)
[ Tue, Feb 18th 2025 ]: MSN
Best Mutual funds: Investment in these flexi caps jumped over 3 times in 10 years
[ Tue, Feb 18th 2025 ]: Investing
Chinese tech stocks extend rally on DeepSeek optimism, Xi meeting private leaders
[ Tue, Feb 18th 2025 ]: MSN
How much is needed to invest in the stock market to retire early and live off passive income?
[ Tue, Feb 18th 2025 ]: MSN
Want to invest like Warren Buffet? Learn from this stock trading bundle
Mon, February 17, 2025
[ Mon, Feb 17th 2025 ]: marketindex
Should you buy the dip on ASX healthcare stocks CSL, Cochlear and Pro Medicus?
[ Mon, Feb 17th 2025 ]: MSN
2 Solid Passive Income Stocks That Paid Dividends Monthly
[ Mon, Feb 17th 2025 ]: Sky
Money blog: Britain's favourite banks revealed - and there's a new winner
[ Mon, Feb 17th 2025 ]: Yahoo
Super Micro Stock Is Dividing the Street. Why SMCI's Great Run Is Under Threat.
[ Mon, Feb 17th 2025 ]: MSN
Lightspeed Commerce's SWOT analysis: stock transformation amid market shifts
[ Mon, Feb 17th 2025 ]: bnnbloomberg
Steelmaker Thyssenkrupp Soars as Defense Gains Add to IPO Merits
[ Mon, Feb 17th 2025 ]: Kiplinger
What to Do When Your ETF Closes
[ Mon, Feb 17th 2025 ]: MSN
Mercury Systems' SWOT analysis: defense tech firm's stock navigates challenges
[ Mon, Feb 17th 2025 ]: MSN
Brokers Suggest Investing in TSMC (TSM): Read This Before Placing a Bet
[ Mon, Feb 17th 2025 ]: MSN
Morgan Stanley discusses Australian gold stocks, sees spot prices falling to $2,700/oz by 4Q25
[ Mon, Feb 17th 2025 ]: MSN
Franklin Resources, Inc. (BEN): Among the Low PE High Dividend Stocks to Buy Now
[ Mon, Feb 17th 2025 ]: Forbes
3 Common Types Of Income And How You Can Maximize Yours
[ Mon, Feb 17th 2025 ]: MSN
Suze Orman: Here's How Much Cash You Should Have Available When You Retire
[ Mon, Feb 17th 2025 ]: Kiplinger
How Amazon Stock Became a Member of the 100,000% Return Club
[ Mon, Feb 17th 2025 ]: WOPRAI
Short squeeze is starting in shares of ORCC at $1 .. 5, after crossing above the $13.056 Trigger Price
[ Mon, Feb 17th 2025 ]: WOPRAI
Short squeeze is starting in shares of OFC at $27 .. 5, after crossing above the $25.691 Trigger Price
[ Mon, Feb 17th 2025 ]: WOPRAI
Short squeeze is starting in shares of OCN at $35 .. 74, after crossing above the $5.428 Trigger Price
[ Mon, Feb 17th 2025 ]: WOPRAI
Short squeeze is starting in shares of OAS at $11 .. 63, after crossing above the $2.392 Trigger Price
[ Mon, Feb 17th 2025 ]: WOPRAI
Short squeeze is starting in shares of NYCB at $1 .. 95, after crossing above the $8.303 Trigger Price
[ Mon, Feb 17th 2025 ]: WOPRAI
Short squeeze is starting in shares of NRZ at $12 .. 15, after crossing above the $8.993 Trigger Price
[ Mon, Feb 17th 2025 ]: WOPRAI
Short squeeze is starting in shares of NR at $6.975, after crossing above the $4.304 Trigger Price

Should you buy the dip on ASX healthcare stocks CSL, Cochlear and Pro Medicus?

CSL and Cochlear are two of Australia's blue-chip healthcare stocks, stalwarts of many investors portfolios, whereas Pro Medicus is likely either a relatively new addition, or is on many investors' shopping lists.
The article discusses the potential investment opportunities in ASX healthcare stocks, focusing on CSL, Cochlear, and Pro Medicus, following a dip in their stock prices. CSL, a global biotech company, experienced a significant drop after reporting a lower-than-expected profit forecast for FY24 due to challenges in its plasma collection business, though its long-term outlook remains positive. Cochlear, known for its hearing implants, saw its shares decline after a weak first-half result, but it is expected to recover with growth in the hearing implant market. Pro Medicus, a medical imaging technology firm, also faced a share price drop despite strong financial performance, attributed to concerns over future growth rates. The article suggests that while these companies face short-term issues, their strong fundamentals and market positions could make them attractive buys during this dip, especially for long-term investors looking at the healthcare sector's growth potential.

Read the Full marketindex Article at:
[ https://www.marketindex.com.au/news/should-you-buy-the-dip-on-asx-healthcare-stocks-csl-cochlear-and-pro-medicus ]